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INTRODUCTION
Aspirin (ASA) and other non-steroidal anti-inflammatory
agents (NSAIDs) cause bronchoconstriction in 10 to 20% of
adult asthmatic patients (1, 2). A recent investigation demon-
strated that the prevalence of ASA-sensitive asthma among
patients with non-atopic asthma was 36.1% based upon lysine
aspirin bronchoprovocation test (L-ASA BPT) results (3).
The mechanism of ASA-induced bronchoconstriction has
not yet been fully defined. However, it is widely accepted that
ASA and other NSAIDs block the cyclo-oxygenase pathway
and that this may cause arachidonate substrates to be divert-
ed to the 5-lipoxygenase pathways. Products of this pathway
can induce chemotaxis via leukotriene B4 and are potent bron-
choconstrictors and secretagogues (4). A recent review (5) em-
phasized the importance of cysteinyl leukotriene (cys-LT) over-
productions in the mechanism of ASA-induced bronchocon-
striction.
The L-ASA BPT has become an alternative diagnostic test
for detecting ASA sensitivity in asthmatic patients, and is used
routinely in Europe and other parts of the world (6, 7). L-ASA
inhalation could induce late asthmatic responses as well as early
asthmatic responses (8).
Although there has been some evidence indicating mast cell
activation after L-ASA inhalantion (9, 10), there has been no
report on indicating cellular activation profiles during late asth-
matic response. To investigate the possible involvement of mast
cell and neutrophil in ASA-induced asthma, we compared
changes of serum NCA and histamine levels during L-ASA
BPT between early and late asthmatic responders.
MATERIALS AND METHODS
Subjects
The 13 ASA-sensitive asthma patients confirmed by positive
L-ASA BPT were classified into two groups: the group I in-
cluded seven patients showing isolated early asthmatic respons-
es and the group II included six dual asthmatic responders. The
clinical characteristics of the study subjects were summarized
in Table 1. Atopy was defined on the basis of skin prick test
results showing more that 2+responses: two or more common
inhalant allergens such as Dermatophagoides farinae, alder, oak,
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Enhanced Serum Neutrophil Chemotactic Activity was Noted in Both
Early and Late Asthmatic Responses During Lysine-Aspirin
Bronchoprovocation Test in ASA-Sensitive Asthmatic Patients
To investigate the pathogenic mechanism of late asthmatic response in comparison
to early asthmatic response, changes of serum neutrophil chemotactic activity (NCA)
using the Boyden chamber method and histamine level using the automated fluoro-
metric analyzer were observed in 13 aspirin (ASA)-sensitive asthma subjects (group
I: 7 early responders and group II: 6 dual responders) during lysine aspirin bronch-
oprovocation test (L-ASA BPT). Sera were collected before, and 30 min and 240 min
after L-ASA BPT. Serum NCA increased significantly after 30 min (p=0.02) and decre-
ased significantly at 240 min (p=0.02) in group I, while serum NCA of group II incr-
eased significantly at 30 min (p=0.04), tending to increase further up to 240 min with
no statistical significance. NCA at 240 min in group II subjects was significantly high-
er than baseline NCA (p=0.02). The serum NCAs collected before and 240 min were
significantly higher in group II than in group I (p<0.05, respectively). There were no
significant changes in serum histamine levels during L-ASA BPT in both groups. NCA
derived from mast cell may contribute to the development of early asthmatic response
induced by L-ASA inhalation. There may be a possible involvement of NCA derived
from mononuclear cells during late asthmatic response.
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rye grass, mugwort, ragweed and Aspergillus spp. (Bencard A-
llergy Service, Brentford, Middlesex, U.K.). Most of them were
treated with inhaled corticosteroid with short acting  2-ago-
nist inhalers as needed.
No subject was investigated within 4 weeks of an upper
respiratory tract infection or an exacerbation of asthma. All the
subjects gave their written informed consent. This study was
approved by the Ajou University Hospital, Suwon, Korea.
Bronchoprovocation test
Airway hyperresponsiveness to methacholine and L-ASA
BPT were performed according to the method described pre-
viously (8). All medications, including theophylline, bron-
chodilators, and steroids, were stopped 48 hr before the pro-
cedure. Pulmonary function was measured with a spirometer,
the FEV1 and maximum mid-expiratory flow (MMEF), before
and during provocation. Normal saline was inhaled as a place-
bo solution. The patients were asked to breathe the nebulized
aerosol up to their vital capacity 10 times. L-ASA (Young-Jin
Co. Seoul, Korea), as a powder containing 1,800 mg of L-ASA
with 200 mg of glycine, was made up freshly on each challenge
day with 10 mL of normal saline to produce a L-ASA solution
containing 180 mg/mL. The L-ASA solutions were delivered
by a DeVilbiss 646 nebulizer (DeVilbiss Co., Somerset, Penn.,
U.S.A.) and connected to a compressed air source (5 L/min).
The challenges with placebo were performed seven days before
the L-ASA BPT. If there was less than a 10% fluctuation of
FEV1 with placebo inhalation, L-ASA BPT from 11.25 up to
180 mg/mL was performed to determine the provocative dose
of L-ASA, which induced more than a 20% fall of FEV1. All
provocations were carried out at the same time of the day. The
FEV1 and MMEF were measured frequently during the first
hour, and then hourly for 8 hr. Late asthmatic responses were
noted from 240 min and 420 min after L-ASA inhalation.
Measurement of serum neutrophil chemotactic activity
Sera were collected from group I and group II subjects be-
fore, 30 min and 240 min after the L-ASA bronchial challe-
nges. Serum NCA was measured using the Boyden chamber
method as described in our previous reports (11, 12). Neutro-
phils were obtained from heparinized whole blood of AB-type
normal volunteers by sedimentation in 6% dextran dextrose
solution followed by centrifugation on Ficoll-Hypaque solu-
tion (specific gravity of 1.077) and the supernatants were aspi-
rated and frozen at -20℃. Cells containing more than 95%
neutrophils were suspended in Hank’ s balanced salt solution
(HBSS) with 0.4% of bovine serum albumin (BSA) at the con-
centration of 1×106 cells/mL. Polycarbonate filter with 5- m
pore size (Osmonics, Livermore, CA, U.S.A.) was topped over
chemotaxin followed by distribution of neutrophil suspension.
The chamber was incubated for 90 min at 37℃in a humid-
ified incubator containing 5% CO2.
Thereafter, the filter was removed, fixed in 100% methanol,
and subsequently stained with Diff Quick stain solution. The
number of neutrophils, which migrated through the filter, was
determined microscopically at 40×objectives. Five fields were
counted per well and the experiments were conducted in qua-
druplicate. The results were expressed as the mean of the num-
ber of migrated neutrophils per field in each sample. Opso-
nized serum was used in the positive control and HBSS with
BSA in the negative control.
Measurement of serum histamine level
Serum was diluted 1/10 with distilled water and was ana-
lyzed immediately. Serum histamine was measured using Asto-
riaTM Histamine Analyzer 300 system (Astoria-Pacific interna-
tional, U.S.A.) with the automated fluorometric procedure as
described by Siraganian (13). The chemistry was separated into
two phases: extraction step to eliminate interference from var-
Patient No. Sex/Age (yr) Duration of asthma (yr) Rhinitis Nasal Polyp PC20 (mg/mL)
Group I 1 F/27 <1 Present Absent 2.5
2 M/46 20 Absent - 0.62
3 F/67 <1 Present Present ND
4 M/37 3 Present Present 1.25
5 F/57 10 Present - 0.31
6 F/45 20 Present - 0.31
7 M/26 5 Absent Present 0.31
Group II 1 F/40 7 Present Present 5.0
2 M/21 4 Present Present 1.25
3 M/30 10 Present Present 0.075
4 M/34 3 Present Present 0.62
5 F/35 15 Present Absent 1.25
6 F/33 2 -- 25
7 F/27 6 Present Present- 0.31
Table 1. Clinical characteristics of the study subjects
Group I; Early response; Group II; Dual response; ND; Not done.44 S.-S. Kim, H.-S. Park, H.-J. Yoon, et al.
ious histamine-related compounds, including Spermine, N-
acetylhistamine, Histidine and Serotonin; and in condensation
step, histamine was reduced with the O-phthalaldehyde re-
agent at an alkaline pH 12.4-12.7. The reaction reached max-
imum fluorescence after 4 min and then acidified to produce
a stable fluorescent complex. The fluorescence was determined
using a fluorometer.
Statistical analysis
The Wilcoxon-signed rank tests, and Mann-Whitney U-test
were applied using SPSS version 7.0 (Chicago, IL, U.S.A.) to
evaluate the statistical differences between the data. A p-value
of 0.05 or less was regarded as significant.
RESULTS
Changes of serum neutrophil chemotactic activity dur-
ing the L-ASA BPT
Sera from groups I and II were collected at 0 (before the chal-
lenge test), 30 and 240 min after the L-ASA BPT. Fig. 1 shows
the changes of serum NCA in group I and group II subjects.
All the subjects of group I showed similar changing patterns:
serum NCA significantly increased (p=0.02) and peaked at 30
min after the L-ASA inhalation, and thereafter decreased at 240
min (p=0.02). When the changes of serum NCA were com-
pared in six subjects with dual asthmatic response (group II),
there were significant increases of serum NCA at 30 min (p=
0.04) after L-ASA inhalation, and they tended to increase fur-
ther up to 240 min, but no statistical significance was reached
(p=0.13). However, NCA collected at 240 min was significant-
ly higher than that collected before the challenges in group
II patients (p=0.02).
Comparison of serum NCA between group I and group II
Fig. 2 demonstrates serum NCA at each time point between
groups II and I. Serum NCAs collected before and those at
240 min were significantly higher in group II than in group
I (p<0.05, respectively), but no statistical significance was
noted in 30 min-samples (p>0.05).
Changes of serum histamine level during L-ASA BPT
in both groups
Fig. 3 shows the changes of serum histamine level during
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Fig. 2. Comparison of serum neutrophil chemotactic activity during
L-ASA bronchoprovocation test between early (E) and dual (D)
asthmatic responders of ASA-sensitive asthmatic patients. Horizon-
tal bars indicate median values.
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Fig. 1. Changes of serum neutrophil chemotactic activity during L-ASA bronchoprovocation test in early asthmatic responders (A) and
dual asthmatic responders (B) of ASA-sensitive asthmatic patients. Horizontal bars indicate median values.
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L-ASA BPT in group I and group II. There were no signifi-
cant changes in histamine level in both group I and group II
during L-ASA BPT (p>0.05, respectively). There were no sig-
nificant correlations between serum NCA and histamine level
at each time point (data not shown).
Effect of anti-IL-8 antibody in serum neutrophil chemo-
tactic activity
In order to evaluate the effect of anti-IL-8 antibody on serum
NCA, sera from two subjects of group I, which had been col-
lected at 30 min after the L-ASA challenges, and sera from two
subjects of group II, which were collected at 240 min after L-
ASA BPT, were used. Each serum was pre-incubated with an
equal volume of anti-IL-8 antibody, and then NCA was mea-
sured as described in the above. Pre-incubation of anti-IL-8
antibody (10  g, R&D, Minn., U.S.A.) did not affect the en-
hanced NCA in either group I or group II as shown in Table 2.
DISCUSSION
Although the pathogenic mechanism of ASA-induced asth-
ma still remains to be further clarified, there has been some
evidence indicating mast cell activation after L-ASA inhala-
tions (9, 10). Increased levels of tryptase, histamine, and cys-
teinyl-leukotrienes after nasal challenge of L-ASA were noted
in nasal lavage fluid of ASA-sensitive asthma and significant
increases of urinary PGD2 and 9 11 -PGF2 were noted after
L-ASA BPT. One report showed increased NCA after oral ASA
challenges (14). In this study, we compared changes of serum
NCA between early and dual asthmatic responders after the
L-ASA BPT. The presence of NCA has been demonstrated in
sera of individuals with asthma after provocation with aller-
gens (15, 16) or non-specific stimuli such as exercise (17). The
origin of these activities is still elusive, although some indi-
rect data would indicate mast cells as the origin in the case of
heat-stable activity, and monocyte/macrophage for the heat-
labile one (15, 16), since the time course for the occurrence of
serum heat-labile activity is clearly different from that of the
heat-stable one. The latter activity showed a quick rise coin-
ciding with or preceding early reduction of FEV1, whereas
heat-labile activity was demonstrated following a second peak,
which coincided with the late asthmatic response (17). In this
study, L-ASA itself did not have NCA. Group I subjects had
a peak of NCA at 30 min after inhalation challenge, followed
Patients
Before anti IL-8 treatment After anti-IL-8 treatment
Baseline 30 min after L-ASA BPT 240 min after L-ASA BPT Baseline 30 min after L-ASA BPT 240 min after L-ASA BPT
A 22,229 26,325 17,365 17,621 23,680 18,389
B 13,056 17,194 14,250 12,416 16,512 12,245
C 26,410 32,597 36,535 26,539 31,488 35,968
D 25,130 30,762 36,394 25,984 32,597 36,309
Table 2. Effect of anti-IL-8 on serum neutrophil chemotactic activity (cells/HPF) which was collected during lysine-ASA bronchoprovo-
cation test 
A, B: Early asthmatic responders; C, D: Dual asthmatic responders.
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Fig. 3. Changes of serum histamine level during L-ASA bronchoprovocation test in early (A) and dual asthmatic responders (B) of ASA-
sensitive asthmatic patients. Horizontal bars indicate median values.
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by a significant decrease in activity at 240 min. In this study,
on the basis of the time course, we speculated that NCA, found
during early asthmatic responses induced by L-ASA inhala-
tion, may have originated from mast cells, but further studies
are needed to characterize NCA released after L-ASA inhala-
tion. These findings could support the evidence of mast cell
activation occurring in early asthmatic response after L-ASA
inhalation reported by Fisher et al. (13).
In this study, enhanced NCA was also noted during late asth-
matic response induced by L-ASA inhalation. In group II sub-
jects, NCA collected at 240 min was significantly higher than
the baseline value and, NCA of group II subjects at 240 min
was significantly higher than that of group I subjects. Based
upon the time sequence, enhanced NCA at 240 min after L-
ASA inhalation found in this study may have been derived
from mononuclear cells.
Recently, several studies supporting evidence of neutrophil
involvement in the pathogenesis of bronchial asthma have been
reported. Inhalation of grain dust was found to induce increas-
ed neutrophil infiltration and enhanced serum NCA to grain
dust (10). In vitro studies revealed the release of substances pre-
senting NCA by bronchial epithelial cells in response to grain
dust (18). In the case of toluene diisocyanate (TDI)-induced
asthma, neutrophilia in bronchoalveolar lavage fluid had been
noted in subjects with late asthmatic reactions induced by iso-
cyanate challenge test (19) and myeloperoxidase (MPO) level
representing neutrophil activation was increased after TDI
bronchial challenges with concordant increase of IL-8 in the
induced sputum of TDI-induced asthma (20). In patients with
severe asthma and those with a history of status asthmaticus,
neutrophil activation was noted in airway mucosa (21, 22). Not
only as mere terminal effector cells, neutrophils can also affect
other cells by releasing various cytokines (23, 24). In this study,
serum NCA was increased during early asthmatic responses
and increased further during late asthmatic response. We also
observed the effect of anti-IL-8 on NCA, as IL-8 is the key
chemokine to induce neutrophil activation and migration. In
this study, pre-incubation of anti-IL-8 antibody did not affect
NCAs in both early and late asthmatic responders. Further
studies will be needed to clarify the role of neutrophil during
ASA-induced asthmatic responses.
Histamine has been known as one of the major chemical
mediators from mast cells/basophils and not from other inflam-
matory cells. In this study, to confirm the role of mast cell/
basophil activation during late asthmatic responses as well as
early asthmatic responses after L-ASA inhalation, we compared
serum histamine level between early and dual asthmatic re-
sponses. There were no significant changes in histamine level
in either groups. Although the serum histamine level may be
used to represent an indirect marker of basophil activation, it
has very low sensitivity since circulating histamine is too re-
mote from the target tissues of asthmatic airway. These find-
ings suggest that the possibility of basophil activation during
late asthmatic responses is very low.
In conclusion, NCA derived from mast cell may contribute
to the development of early asthmatic response induced by L-
ASA inhalation. There may be a possible involvement of en-
hanced NCA derived from mononuclear cells during late asth-
matic response induced by L-ASA inhalation.
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